Back

Understanding ezetimibe’s role in lipid lowering and its limited impact on venous thromboembolism risk

European Heart Journal

13 December 2024
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure

Contributors

Ioannis T Farmakis
Ioannis T Farmakis

Author

Ludwig Maximilians University Munich , Germany

Stavros V Konstantinides
Stavros V Konstantinides

Author

Luca Valerio
Luca Valerio

Author

University Medical Center of Mainz Mainz , Germany

You may be interested in
thumbnail
Congress Presentation
Statins for venous thromboembolism prevention: old dog, new tricks
1 September 2020
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
15 April 2024
thumbnail
Congress Presentation
Ezetimibe use and mortality after myocardial infarction: a nationwide cohort study
31 August 2024
thumbnail
Congress Presentation
Monetary costs and LDL-C reduction from upfront combination lipid-lowering therapy with ezetimibe in an irish ACS cohort
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources